Patients with inoperable lung cancer treated with a combination of thermal ablation and radiotherapy were able to add two years to their survival times, according to Brown University Medical School researchers.
Dr. Damian Dupuy, an interventional radiologist at Brown, and colleagues enrolled 41 patients with inoperable stage I/II non-small cell lung cancer tumors who underwent thermal ablation and radiotherapy between 1998 and 2005. The investigators performed 37 radiofrequency and four microwave ablation procedures, followed within 90 days by either external-beam radiotherapy or brachytherapy in 27 and 14 patients, respectively (J Vasc Interv Radiol 2006;17[7]:1117-1124).
None of the patients were expected to live longer than one year, according to the panel of specialists who selected them for the study. The combination therapy, however, prolonged the patients' lives about two years beyond that point.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
What if Radiology Turns Out Exactly the Way We Predict it Will?
May 19th 2025Whether it is reimbursement cuts or continued attempts to push non-radiologist image interpretation, where do we draw the line between inspired protest and misspent energy criticizing things that are doomed to fail or things we have no control over?
What a New PSMA PET/CT Study Reveals About Local PCa Treatment and High-Risk Recurrence
May 16th 2025For patients at high-risk for biochemical recurrence of prostate cancer, PSMA PET/CT findings revealed that 77 percent had one or more prostate lesions after undergoing local radiation therapy or radical prostatectomy, according to a recent study.